{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:02:10Z","timestamp":1779760930095,"version":"3.53.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Youth Project of Shandong Provincial Natural Science Foundation","award":["No. ZR2023QH414"],"award-info":[{"award-number":["No. ZR2023QH414"]}]},{"name":"The Youth Project of Shandong Provincial Natural Science Foundation","award":["No. ZR2024QH655"],"award-info":[{"award-number":["No. ZR2024QH655"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46560-4","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:24:00Z","timestamp":1775294640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deciphering oxidative stress-related heterogeneity and developing a prognostic signature for colorectal cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Linyun","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyou","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"46560_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA. Cancer J. Clin."},{"key":"46560_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan, E. et al. Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN. Gut 72, 338\u2013344 (2023).","journal-title":"Gut"},{"key":"46560_CR3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMra1513581","volume":"374","author":"WB Strum","year":"2016","unstructured":"Strum, W. B. Colorectal adenomas. N. Engl. J. Med. 374, 1065\u20131075 (2016).","journal-title":"N. Engl. J. Med."},{"key":"46560_CR4","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.3390\/cancers12113336","volume":"12","author":"D Basak","year":"2020","unstructured":"Basak, D., Uddin, M. N. & Hancock, J. The role of oxidative stress and its counteractive utility in colorectal cancer (CRC). Cancers (Basel) 12, 3336 (2020).","journal-title":"Cancers (Basel)"},{"key":"46560_CR5","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/ijc.33018","volume":"147","author":"D Boakye","year":"2020","unstructured":"Boakye, D. et al. Blood markers of oxidative stress are strongly associated with poorer prognosis in colorectal cancer patients. Int. J. Cancer. 147, 2373\u20132386 (2020).","journal-title":"Int. J. Cancer."},{"key":"46560_CR6","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3390\/ijms21072473","volume":"21","author":"P Vodicka","year":"2020","unstructured":"Vodicka, P. et al. Oxidative damage in sporadic colorectal cancer: Molecular mapping of base excision repair glycosylases in colorectal cancer patients. Int. J. Mol. Sci. 21, 2473 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"46560_CR7","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1016\/j.molcel.2021.08.018","volume":"81","author":"C Lennicke","year":"2021","unstructured":"Lennicke, C. & Cochem\u00e9, H. M. Redox metabolism: ROS as specific molecular regulators of cell signaling and function. Mol. Cell 81, 3691\u20133707 (2021).","journal-title":"Mol. Cell"},{"key":"46560_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.tcb.2020.03.002","volume":"30","author":"IS Harris","year":"2020","unstructured":"Harris, I. S. & DeNicola, G. M. The complex interplay between antioxidants and ROS in cancer. Trends Cell Biol. 30, 440\u2013451 (2020).","journal-title":"Trends Cell Biol."},{"key":"46560_CR9","doi-asserted-by":"publisher","first-page":"H2023","DOI":"10.1152\/ajpheart.01283.2006","volume":"292","author":"DX Zhang","year":"2007","unstructured":"Zhang, D. X. & Gutterman, D. D. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 292, H2023-2031 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"46560_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ccr.2006.08.015","volume":"10","author":"PT Schumacker","year":"2006","unstructured":"Schumacker, P. T. Reactive oxygen species in cancer cells: Live by the sword, die by the sword. Cancer Cell 10, 175\u2013176 (2006).","journal-title":"Cancer Cell"},{"key":"46560_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2010.04.002","author":"H Rb","year":"2010","unstructured":"Rb, H. & Ns, C. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem. Sci. https:\/\/doi.org\/10.1016\/j.tibs.2010.04.002 (2010).","journal-title":"Trends Biochem. Sci."},{"key":"46560_CR12","first-page":"695","volume":"25","author":"W Ws","year":"2006","unstructured":"Ws, W. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 25, 695\u2013705 (2006).","journal-title":"Cancer Metastasis Rev."},{"key":"46560_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-022-00859-2","volume":"29","author":"C-L Kuo","year":"2022","unstructured":"Kuo, C.-L. et al. Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: Foe or friend?. J. Biomed. Sci. 29, 74 (2022).","journal-title":"J. Biomed. Sci."},{"key":"46560_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-318126","author":"B M","year":"2019","unstructured":"M, B. et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut https:\/\/doi.org\/10.1136\/gutjnl-2018-318126 (2019).","journal-title":"Gut"},{"key":"46560_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.772101","author":"L M","year":"2021","unstructured":"M, L., D, C., M, F., G, D. & G, S. Inflammatory bowel disease and risk of colorectal cancer: An overview from pathophysiology to pharmacological prevention. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.772101 (2021).","journal-title":"Front. Pharmacol."},{"key":"46560_CR16","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","volume":"140","author":"TA Ullman","year":"2011","unstructured":"Ullman, T. A. & Itzkowitz, S. H. Intestinal inflammation and cancer.. Gastroenterology 140, 1807\u20131816 (2011).","journal-title":"Gastroenterology"},{"key":"46560_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134406","author":"S Ml","year":"2015","unstructured":"Ml, S., Df, P., Le, M. & Rk, W. Differential gene expression in colon tissue associated with diet, lifestyle, and related oxidative stress. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0134406 (2015).","journal-title":"PLoS ONE"},{"key":"46560_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4251\/wjgo.v6.i3.55","volume":"6","author":"WL Stone","year":"2014","unstructured":"Stone, W. L., Krishnan, K., Campbell, S. E. & Palau, V. E. The role of antioxidants and pro-oxidants in colon cancer.. World J. Gastrointest. Oncol. 6, 55\u201366 (2014).","journal-title":"World J. Gastrointest. Oncol."},{"key":"46560_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.06.025","author":"G Fr","year":"2019","unstructured":"Fr, G. & Si, G. Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025 (2019).","journal-title":"Immunity"},{"key":"46560_CR20","doi-asserted-by":"publisher","first-page":"117727191875539","DOI":"10.1177\/1177271918755391","volume":"13","author":"S Kumari","year":"2018","unstructured":"Kumari, S., Badana, A. K., G, M. M., G, S. & Malla, R. Reactive oxygen species: A key constituent in cancer survival. Biomark Insights 13, 1177271918755391 (2018).","journal-title":"Biomark Insights"},{"key":"46560_CR21","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data.. Cell 184, 3573-3587.e29 (2021).","journal-title":"Cell"},{"key":"46560_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-Seq data.. BMC Bioinformatics 14, 7 (2013).","journal-title":"BMC Bioinformatics"},{"key":"46560_CR23","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: A class discovery tool with confidence assessments and item tracking.. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"46560_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene Ontology: Tool for the unification of biology. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"46560_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"46560_CR26","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"46560_CR27","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"46560_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"46560_CR29","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D.-C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: Efficient and comprehensive analysis of somatic variants in cancer.. Genome Res. 28, 1747\u20131756 (2018).","journal-title":"Genome Res."},{"key":"46560_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani, R. The LASSO method for variable selection in the COX model. Stat. Med. 16, 385\u2013395 (1997).","journal-title":"Stat. Med."},{"key":"46560_CR31","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550\u20131558 (2018).","journal-title":"Nat. Med."},{"key":"46560_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu, J. et al. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 12, 21 (2020).","journal-title":"Genome Med."},{"key":"46560_CR33","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"D Maeser","year":"2021","unstructured":"Maeser, D., Gruener, R. F. & Huang, R. S. oncoPredict: An R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief. Bioinform. 22, bbab260 (2021).","journal-title":"Brief. Bioinform."},{"key":"46560_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrclinonc.2016.171","volume":"14","author":"CJA Punt","year":"2017","unstructured":"Punt, C. J. A., Koopman, M. & Vermeulen, L. From tumour heterogeneity to advances in precision treatment of colorectal cancer. Nat. Rev. Clin. Oncol. 14, 235\u2013246 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"46560_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1101\/gad.348226.120","volume":"35","author":"J Li","year":"2021","unstructured":"Li, J., Ma, X., Chakravarti, D., Shalapour, S. & DePinho, R. A. Genetic and biological hallmarks of colorectal cancer. Genes Dev. 35, 787\u2013820 (2021).","journal-title":"Genes Dev."},{"key":"46560_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41698-023-00451-3","volume":"7","author":"J H\u00f6hn","year":"2023","unstructured":"H\u00f6hn, J. et al. Colorectal cancer risk stratification on histological slides based on survival curves predicted by deep learning. NPJ. Precis Oncol. 7, 98 (2023).","journal-title":"NPJ. Precis Oncol."},{"key":"46560_CR37","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","volume":"19","author":"A Jemal","year":"2010","unstructured":"Jemal, A., Center, M. M., DeSantis, C. & Ward, E. M. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev. 19, 1893\u20131907 (2010).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"46560_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1678096","author":"J Cheng","year":"2025","unstructured":"Cheng, J. et al. Membraneless organelles-based integrative analysis constructs an immune-related prognostic signature and identifies NRG1 as a novel methylation biomarker in colorectal cancer. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1678096 (2025).","journal-title":"Front. Immunol."},{"key":"46560_CR39","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12935-025-03998-2","volume":"25","author":"J Cheng","year":"2025","unstructured":"Cheng, J. et al. Cell-cycle-related transcriptional factor DLX4: A novel prognostic biomarker and potential therapeutic target in colorectal cancer. Cancer Cell Int. 25, 370 (2025).","journal-title":"Cancer Cell Int."},{"key":"46560_CR40","doi-asserted-by":"publisher","first-page":"10623","DOI":"10.1007\/s00432-023-04914-9","volume":"149","author":"X Wu","year":"2023","unstructured":"Wu, X., Zhu, Z. & Gai, M. Prognostic modelling of colorectal cancer based on oxidative stress-related genes. J. Cancer Res. Clin. Oncol. 149, 10623\u201310631 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"46560_CR41","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12859-023-05203-5","volume":"24","author":"R Chen","year":"2023","unstructured":"Chen, R. & Wei, J.-M. Integrated analysis identifies oxidative stress-related lncRNAs associated with progression and prognosis in colorectal cancer. BMC Bioinformatics 24, 76 (2023).","journal-title":"BMC Bioinformatics"},{"key":"46560_CR42","doi-asserted-by":"publisher","first-page":"1125203","DOI":"10.3389\/fimmu.2023.1125203","volume":"14","author":"Y Guo","year":"2023","unstructured":"Guo, Y. et al. Construction and validation of a signature for T cell-positive regulators related to tumor microenvironment and heterogeneity of gastric cancer. Front. Immunol. 14, 1125203 (2023).","journal-title":"Front. Immunol."},{"key":"46560_CR43","doi-asserted-by":"publisher","first-page":"1054700","DOI":"10.3389\/fimmu.2023.1054700","volume":"14","author":"R Zhang","year":"2023","unstructured":"Zhang, R. et al. Developing an m5C regulator\u2013mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer. Front. Immunol. 14, 1054700 (2023).","journal-title":"Front. Immunol."},{"key":"46560_CR44","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10495-013-0932-5","volume":"19","author":"R Schneider-Stock","year":"2014","unstructured":"Schneider-Stock, R. Death-associated kinase (DAPK): A cancer \u2018gene chameleon\u2019. Apoptosis 19, 285 (2014).","journal-title":"Apoptosis"},{"key":"46560_CR45","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/36599","volume":"390","author":"B Inbal","year":"1997","unstructured":"Inbal, B. et al. DAP kinase links the control of apoptosis to metastasis. Nature 390, 180\u2013184 (1997).","journal-title":"Nature"},{"key":"46560_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/35050500","volume":"3","author":"T Raveh","year":"2001","unstructured":"Raveh, T., Droguett, G., Horwitz, M. S., DePinho, R. A. & Kimchi, A. DAP kinase activates a p19ARF\/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat. Cell Biol. 3, 1\u20137 (2001).","journal-title":"Nat. Cell Biol."},{"key":"46560_CR47","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s10495-013-0923-6","volume":"19","author":"H-Y Chen","year":"2014","unstructured":"Chen, H.-Y., Lee, Y.-R. & Chen, R.-H. The functions and regulations of DAPK in cancer metastasis. Apoptosis 19, 364\u2013370 (2014).","journal-title":"Apoptosis"},{"key":"46560_CR48","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1038\/cdd.2008.121","volume":"15","author":"D Gozuacik","year":"2008","unstructured":"Gozuacik, D. et al. DAP-kinase is a mediator of endoplasmic reticulum stress-induced caspase activation and autophagic cell death. Cell. Death Differ. 15, 1875\u20131886 (2008).","journal-title":"Cell. Death Differ."},{"key":"46560_CR49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/path.1951","volume":"209","author":"R Schneider-Stock","year":"2006","unstructured":"Schneider-Stock, R. et al. Close localization of DAP-kinase positive tumour-associated macrophages and apoptotic colorectal cancer cells. J. Pathol. 209, 95\u2013105 (2006).","journal-title":"J. Pathol."},{"key":"46560_CR50","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41419-019-2122-z","volume":"10","author":"S Steinmann","year":"2019","unstructured":"Steinmann, S. et al. DAPK1 loss triggers tumor invasion in colorectal tumor cells. Cell. Death Dis. 10, 895 (2019).","journal-title":"Cell. Death Dis."},{"key":"46560_CR51","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jcmgh.2023.05.007","volume":"16","author":"Q Li","year":"2023","unstructured":"Li, Q. et al. Activation of Sphingomyelin Phosphodiesterase 3 in liver regeneration impedes the progression of colorectal cancer liver metastasis via exosome-bound intercellular transfer of ceramides. Cell. Mol. Gastroenterol. Hepatol. 16, 385\u2013410 (2023).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"46560_CR52","doi-asserted-by":"publisher","first-page":"944286","DOI":"10.3389\/fimmu.2022.944286","volume":"13","author":"Z Liang","year":"2022","unstructured":"Liang, Z. et al. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma. Front. Immunol. 13, 944286 (2022).","journal-title":"Front. Immunol."},{"key":"46560_CR53","doi-asserted-by":"publisher","first-page":"886949","DOI":"10.3389\/fgene.2022.886949","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Effects of inflammatory response genes on the immune microenvironment in colorectal cancer. Front. Genet. 13, 886949 (2022).","journal-title":"Front. Genet."},{"key":"46560_CR54","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10654-017-0262-y","volume":"32","author":"K Nimptsch","year":"2017","unstructured":"Nimptsch, K. et al. Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer: A Mendelian Randomization analysis using data from three large cohort studies. Eur. J. Epidemiol. 32, 419\u2013430 (2017).","journal-title":"Eur. J. Epidemiol."},{"key":"46560_CR55","doi-asserted-by":"publisher","first-page":"119524","DOI":"10.1016\/j.lfs.2021.119524","volume":"278","author":"D Chakraborty","year":"2021","unstructured":"Chakraborty, D., Jin, W. & Wang, J. The bifurcated role of adiponectin in colorectal cancer. Life Sci. 278, 119524 (2021).","journal-title":"Life Sci."},{"key":"46560_CR56","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/bjc.2011.259","volume":"105","author":"MC Gornick","year":"2011","unstructured":"Gornick, M. C., Rennert, G., Moreno, V. & Gruber, S. B. Adiponectin gene and risk of colorectal cancer. Br. J. Cancer 105, 562\u2013564 (2011).","journal-title":"Br. J. Cancer"},{"key":"46560_CR57","doi-asserted-by":"publisher","first-page":"e172579","DOI":"10.1001\/jamaoncol.2017.2579","volume":"3","author":"M Scurr","year":"2017","unstructured":"Scurr, M. et al. Effect of modified vaccinia ankara-5T4 and Low-dose cyclophosphamide on antitumor immunity in metastatic colorectal cancer: A randomized clinical trial. JAMA Oncol. 3, e172579 (2017).","journal-title":"JAMA Oncol."},{"key":"46560_CR58","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(15)00216-8","volume":"16","author":"C Tournigand","year":"2015","unstructured":"Tournigand, C. et al. Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): A randomised, open-label, phase 3 trial. Lancet Oncol. 16, 1493\u20131505 (2015).","journal-title":"Lancet Oncol."},{"key":"46560_CR59","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jcyt.2023.07.006","volume":"25","author":"W Choi","year":"2023","unstructured":"Choi, W. et al. Phase 1 trial of 4-1BB-based adoptive T-cell therapy targeting human telomerase reverse transcriptase in patients with advanced refractory solid tumors. Cytotherapy 25, 1236\u20131241 (2023).","journal-title":"Cytotherapy"},{"key":"46560_CR60","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1158\/1078-0432.CCR-14-0303","volume":"21","author":"I Puzanov","year":"2015","unstructured":"Puzanov, I. et al. A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors. Clin. Cancer Res. 21, 701\u2013711 (2015).","journal-title":"Clin. Cancer Res."},{"key":"46560_CR61","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41573-022-00415-5","volume":"21","author":"G Petroni","year":"2022","unstructured":"Petroni, G., Buqu\u00e9, A., Coussens, L. M. & Galluzzi, L. Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. Nat. Rev. Drug Discov. 21, 440\u2013462 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"46560_CR62","doi-asserted-by":"publisher","first-page":"118722","DOI":"10.1016\/j.ecoenv.2025.118722","volume":"302","author":"J Cheng","year":"2025","unstructured":"Cheng, J. et al. Selenium exposure on breast cancer risk and progression: Comprehensive analysis identifies MSRB1 as a novel therapeutic target. Ecotoxicol. Environ. Saf. 302, 118722 (2025).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"46560_CR63","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","volume":"20","author":"C Li","year":"2021","unstructured":"Li, C., Teixeira, A. F., Zhu, H.-J. & Ten Dijke, P. Cancer associated-fibroblast-derived exosomes in cancer progression. Mol. Cancer 20, 154 (2021).","journal-title":"Mol. Cancer"},{"key":"46560_CR64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13045-022-01273-9","volume":"15","author":"Y Lu","year":"2022","unstructured":"Lu, Y. et al. Gut microbiota influence immunotherapy responses: Mechanisms and therapeutic strategies. J. Hematol. Oncol. 15, 47 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"46560_CR65","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s40001-023-01535-3","volume":"28","author":"J Zhao","year":"2023","unstructured":"Zhao, J. et al. Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma. Eur. J. Med. Res. 28, 571 (2023).","journal-title":"Eur. J. Med. Res."},{"key":"46560_CR66","doi-asserted-by":"publisher","first-page":"e14784","DOI":"10.7717\/peerj.14784","volume":"11","author":"S Ma","year":"2023","unstructured":"Ma, S. et al. A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma. PeerJ 11, e14784 (2023).","journal-title":"PeerJ"},{"key":"46560_CR67","doi-asserted-by":"publisher","first-page":"991881","DOI":"10.3389\/fphar.2022.991881","volume":"13","author":"S Cao","year":"2022","unstructured":"Cao, S., Chen, C., Gu, D., Wang, Z. & Xu, G. Establishment and external verification of an oxidative stress-related gene signature to predict clinical outcomes and therapeutic responses of colorectal cancer. Front. Pharmacol. 13, 991881 (2022).","journal-title":"Front. Pharmacol."},{"key":"46560_CR68","doi-asserted-by":"publisher","first-page":"1200017","DOI":"10.3389\/fphar.2023.1200017","volume":"14","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. Constructing a cancer stem cell related prognostic model for predicting immune landscape and drug sensitivity in colorectal cancer. Front. Pharmacol. 14, 1200017 (2023).","journal-title":"Front. Pharmacol."},{"key":"46560_CR69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejca.2020.08.024","volume":"140","author":"D Malka","year":"2020","unstructured":"Malka, D. et al. Immune scores in colorectal cancer: Where are we?. Eur. J. Cancer 140, 105\u2013118 (2020).","journal-title":"Eur. J. Cancer"},{"key":"46560_CR70","doi-asserted-by":"publisher","first-page":"808964","DOI":"10.3389\/fimmu.2021.808964","volume":"12","author":"Z Bai","year":"2021","unstructured":"Bai, Z. et al. Tumor-infiltrating lymphocytes in colorectal cancer: The fundamental indication and application on immunotherapy. Front Immunol 12, 808964 (2021).","journal-title":"Front Immunol"},{"key":"46560_CR71","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/his.14713","volume":"81","author":"PD Bell","year":"2022","unstructured":"Bell, P. D. & Pai, R. K. Immune response in colorectal carcinoma: A review of its significance as a predictive and prognostic biomarker. Histopathology 81, 696\u2013714 (2022).","journal-title":"Histopathology"},{"key":"46560_CR72","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3390\/cancers3022160","volume":"3","author":"J Conti","year":"2011","unstructured":"Conti, J. & Thomas, G. The role of tumour stroma in colorectal cancer invasion and metastasis. Cancers (Basel) 3, 2160\u20132168 (2011).","journal-title":"Cancers (Basel)"},{"key":"46560_CR73","doi-asserted-by":"publisher","first-page":"19297","DOI":"10.1038\/s41598-023-45558-6","volume":"13","author":"C Feng","year":"2023","unstructured":"Feng, C. et al. A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer. Sci. Rep. 13, 19297 (2023).","journal-title":"Sci. Rep."},{"key":"46560_CR74","doi-asserted-by":"publisher","first-page":"999084","DOI":"10.3389\/fimmu.2022.999084","volume":"13","author":"M Sun","year":"2022","unstructured":"Sun, M. et al. Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer. Front. Immunol. 13, 999084 (2022).","journal-title":"Front. Immunol."},{"key":"46560_CR75","doi-asserted-by":"publisher","first-page":"1186862","DOI":"10.3389\/fgene.2023.1186862","volume":"14","author":"Y Xiao","year":"2023","unstructured":"Xiao, Y. et al. A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer. Front. Genet. 14, 1186862 (2023).","journal-title":"Front. Genet."},{"key":"46560_CR76","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1016\/S1470-2045(16)30406-5","volume":"17","author":"GT Gibney","year":"2016","unstructured":"Gibney, G. T., Weiner, L. M. & Atkins, M. B. Predictive biomarkers for checkpoint inhibitor-based immunotherapy. Lancet Oncol. 17, e542\u2013e551 (2016).","journal-title":"Lancet Oncol."},{"key":"46560_CR77","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S0140-6736(17)33297-X","volume":"391","author":"T Powles","year":"2018","unstructured":"Powles, T. et al. Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): A multicentre, open-label, phase 3 randomised controlled trial. Lancet 391, 748\u2013757 (2018).","journal-title":"Lancet"},{"key":"46560_CR78","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1056\/NEJMoa1613493","volume":"376","author":"DP Carbone","year":"2017","unstructured":"Carbone, D. P. First-line Nivolumab in stage IV or recurrent non-small-cell lung cancer. N. Engl. J. Med. 376, 2415\u20132426 (2017).","journal-title":"N. Engl. J. Med."},{"key":"46560_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-019-00143-8","author":"H Ledford","year":"2019","unstructured":"Ledford, H. Highly mutated cancers respond better to immune therapy. Nature https:\/\/doi.org\/10.1038\/d41586-019-00143-8 (2019).","journal-title":"Nature"},{"key":"46560_CR80","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","volume":"51","author":"RM Samstein","year":"2019","unstructured":"Samstein, R. M. et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat. Genet. 51, 202\u2013206 (2019).","journal-title":"Nat. Genet."},{"key":"46560_CR81","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1158\/2326-6066.CIR-19-0149","volume":"7","author":"AM Goodman","year":"2019","unstructured":"Goodman, A. M., Sokol, E. S., Frampton, G. M., Lippman, S. M. & Kurzrock, R. Microsatellite-stable tumors with high mutational burden benefit from immunotherapy. Cancer Immunol. Res. 7, 1570\u20131573 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"46560_CR82","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrc.2016.154","volume":"17","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan, M., Johnson, B. A., Lutz, E. R., Laheru, D. A. & Jaffee, E. M. Targeting neoantigens to augment antitumour immunity. Nat. Rev. Cancer 17, 209\u2013222 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"46560_CR83","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ccell.2021.04.005","volume":"39","author":"O Klein","year":"2021","unstructured":"Klein, O. et al. Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1\/CTLA-4 combination immunotherapy. Cancer Cell 39, 592\u2013593 (2021).","journal-title":"Cancer Cell"},{"key":"46560_CR84","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.annonc.2020.07.001","volume":"31","author":"V Prasad","year":"2020","unstructured":"Prasad, V. & Addeo, A. The FDA approval of pembrolizumab for patients with TMB >10 mut\/Mb: Was it a wise decision? No.. Ann. Oncol. 31, 1112\u20131114 (2020).","journal-title":"Ann. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46560-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46560-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46560-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T01:02:15Z","timestamp":1779757335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46560-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46560"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46560-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"24 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16245"}}